CYP vs EBR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CYP

CYNATA THR FPO [CYP]

47LOW

EBR

EBR SYSTEM CDI FORUS [EBR]

47LOW

Score Breakdown

CYP EBR
Technical
49
57
Catalyst
50
50
Sentiment
50
50
Fundamental
35
66
Momentum
67
33
Risk Gate
42
46

Key Metrics

CYP Metric EBR
$66.5MMarket Cap$322.1M
191KAvg Volume (20d)465K
N/AShort Interest+0.0%
$0.43552-Week High$2.080
$0.14052-Week Low$0.640
-1.8%Daily Change+0.0%
$0.275Entry Price$0.685
-113.0%ROE-195.3%
N/AProfit MarginN/A

Active Signals

CYP Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Volume surging at 2.2x normal while price falls — heavy selling pressure
Drifting lower — down 5.2% over the last 5 days
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (1.3 quarters)
4C filed 2026-01-28

EBR Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
4C filed 2026-03-18
Very high P/S ratio (199.2x)

Ask Scout AI to compare CYP and EBR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYP Full Analysis → EBR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).